USFDA Approves High BP Drug by Glenmark - medtigo



USFDA Approves High BP Drug by Glenmark

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp



The United States Food and Drug Administration (US FDA) has granted final approval to Glenmark Pharmaceuticals Limited for Nicardipine Hydrochloride Capsules, 20 mg and 30 mg, the generic version of Chiesi USA, Inc.’s Cardene Capsules, 20 mg.  

Glenmark Pharmaceuticals Inc., USA will distribute Nicardipine Hydrochloride Capsules, 20 mg, and 30 mg, in the United States, according to an official statement from the firm.  

As per Live Mint, according to IQVIA sales statistics for the 12-month period ending in October 2022, the Cardene Capsules, 20 mg, and 30 mg market generated roughly $10.9 million in annual sales.  

Currently, Glenmark has 178 pharmaceuticals approved for distribution in the United States and 46 ANDAs pending clearance with the US Food and Drug Administration.  

In addition to these internal filings, Glenmark continues to find and investigate external development collaborations to augment and expedite the expansion of its existing pipeline and portfolio, according to the statement.  

In a warning letter addressed to Glenn Saldanha, Chairman and Managing Director of Glenmark Pharmaceuticals, the USFDA noted a number of breaches at the Goa-based facility in Bardez that produces medicinal formulations.  

According to the US Health Authority, the warning notice details major violations of Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceuticals.  

The US FDA inspected the manufacturing facility from May 12 to May 20. According to the government, the company’s drug goods are contaminated because it’s manufacturing, processing, packaging, or holding techniques, facilities, or controls do not adhere to CGMP standards. 


Leave a Reply


Free CME credits

Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.

Digital Certificate PDF

On course completion, you will receive a full-sized presentation quality digital certificate.

medtigo Simulation

A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.

medtigo Points

medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
  • Registration with medtigo = 10 points
  • 1 visit to medtigo’s website = 1 point
  • Interacting with medtigo posts (through comments/clinical cases etc.) = 5 points
  • Attempting a game = 1 point
  • Community Forum post/reply = 5 points

    *Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.

All Your Certificates in One Place

When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.

Our Certificate Courses